pagiantmetknicksfan@yahoo.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Then buy at $1 plus
of course we do. It is science...well established and accepted science. Again tell me why the science doesnt work? Why Camargo is running with this? Why Pfizer is using this concept too? It works and is proven.
Is there anything int he trials to indicate any reason why it doesn't work?
Or the same shares being sold back and forth by the same folks....then the stock runs....I have seen it before and will see it again....or shares sold short that need to be bought back.
Again, no one with any reason why the company is not going to be ridiculously successful...
Really? So there is no value in 20 approved drugs with a market at what 200 million dollars? And no value in all the other drugs pending approval and in development? lol
How much would it cost to develop these drugs? lol
I guess that is today's angle though. Evaluating a pharma with 20 approved drugs and 10 more in development based purely on current earnings. got it...obviously blatantly incorrect but thats fine.
Last week you told me they were diluting and when shown they have plenty of cash, you noted that it was now retail selling and now it is P/E ratios?
What will tomorrow hold?
Until there is a legitimate reason presented as to why this these products won't work (and we all know they will) the company will be incredibly undervalued.
Trials are all going to be great and continue to be great.
Are there forces out there manipulating the price daily to discourage investors...yep same thing and then the stock runs and people that sold sit back and go "I knew it but I sold....when there was no rational reason for it be at those prices"
25-40 approved drugs, pending drugs, development drugs, plus others in development with different partners--Non ART
Positive ART drug trials received and more fully expected in 8 billion dollar market
Further trials all expected to be positive
Numerous patents
Incredible leadership leading the company...attracting top talent from larger pharmas willing to come to a small company shows confidence.
No one can present any legitimate reason why Elite's ART doesn't work, won't work, won't be approved and because it is modular would represent a shift in the entire market. Elite has more products in development to prevent Abuse then anyone as far as I know
INCREDIBLY UNDERVALUED - No one is talking about the actual value and chances for real success....So when people talk about the transfer of wealth from the impatient to the patient...this is what that means.
Elite is highly likely to be successful and the returns if they are are many possible many many multiples of the current stock price....Simple
R&D companies are valued at their future potential or there would never be such thing as an R&D company....
At a 20 p/e ratio elite needs what.... 6m in earnings? You dont think they would get multiple x of that just on the generics...
So if you are just evaluating elite on the currently launched drugs, you would have a point but what you are actually showing is just how undervalued Elite is...
Products are going to triple and these revenues will increase exponentially....and none of that really matters since it is all about the R&D ADT program.
Now is the stock heavily manipulated every day, 24/7 in order to hold the price down? obviously lol
yeah with 20 approved drugs, more launching, another 10 or so pending approval, and in development with other partners, there sure is a lot going on for this company. Most exciting is obviously the massive opportunity for the ADT line of Opioids. 3 trialed and 4 more in active development....What is that market on just those? $3-$4 billion?
Point of service...lol
LOL....We all know no matter what study is or is not required here, there is no reason to think the results won't be positive. There really is no reason to do an efficacy study unless the FDA wants that box checked. Nothing new is really being introduced here and those that know, which is actually everyone that has looked into it, understand this stock is going to blow up. Camargo has been in in front of this from the beginning
Now is there constant manipulation to shake investors now and later...of course...we see the non retail MMs everyday all day. I haven't even watched level 2 this week and I can guess that BMAK continues to trap the bid and ask with hidden bids and asks and BKMM is also playing around in there.
Now have these MMs or those using these MMs hired people to write false information in places like Hotstocked to disseminate false information? It would seem that way.
The reason why is obvious....20 something already approved drugs, another 10 in development with some pending approval too...
And this doesn't even include the ART products...which we all know will be approved.
Doesn't even have to be big pharma, just a sales and marketing group or other possible investment opportunities. We already know Nasrat has been meeting with folks. So many possibilities at this point.
You claimed it...but can't tell me why LPC would be tapped to such amount. Again saying some see it when others see non retail manipulating the price down...
You can't have it both ways. If you claim it then tell where all this money is being spent since the only facts presented are basic math and logic by me.
So which trials for which additional products do you claim are being funded now. That's a lot of cash in hand which would cover serious trials on quite a few products.
Your facts don't add up. Simple...lol
Again you claimed all this dilution when they have lots of cash. And for them to reach 9.9% that would be about another 10m raised over the 7m they already have which means you are claiming many many trials on many products.
How many additional drugs and trials are you exactly claiming are occurring?
I am saying there is little dilution via LPC.
So what exactly are you claiming? Why do you think they need all these extra millions you are claiming?
Again red herring. Explain why 13gs would be posted..lol
I believe you already did that on your own with your claims and basic math. I never claimed 13gs. You noted something about 9.9% which was a red herring type argument.
You said you can tell dilution based on trading but really we all know it has been mostly non retail working to hold the price down. Many noted it on an almost daily basis.
I haven't made any claims really because your claims haven't been based on any facts you have noted. So no facts to refute or discuss except your opinion based on trading which is actually opposite what we have seen.
Since you are claiming all this dilution which is false and they have 7.5m in just cash per last q thus they must need all this cash you claim for something. Current revenues cover most daily operating costs outside of R&D and the current products have been developed outside of trials....
The only explanation for all this extra cash you claim is being taken now would be trials.
Pretty obvious based on what you claim really.
So you are saying numerous other trials are underway then right? LOL. .
Or you can just look at the q reports...company has 7.5m in cash and runs basic operations outside of the ART program almost neutral
Wrong. It is in the filings. So if a claim is made that there is all this ongoing dilution one can see from the filings that it is not true.
Just stating 9.9% means nothing. Explain how it is supposed to mean something and how it relates to the current shares....I will give you a hint...it's false information. More of a red herring.
Really? Tell me how many shares have been sold to LPC in the past year?
This is false information again.
Everyone knows this is incredibly undervalued and will go on a long run at some point. That is a fact.
Surprised that non retail MMs have manipulated the stock price and killed the run? You mean like every day for the past few months....When it goes it will go. Just like last time....
That means very little in regards to LPC as was noted by the poster. Why should that worry me? Do you know who owns those warrants? Actually your analysis disproves the posters point about LPC....
More then that...much more really
Wait you mean Nasrat didn't lie and intentionally deceive investors after all? Shocked I tell you. SHocked!!!
They have $7.5m in cash as of last Q and operations generally runs cash neutral outside of R&D. And many of the trials needed on the three products are already done. If they diluted the company 5% that would enough for further trials not counting the cash they already have on hand......Plus they just got a milestone payment today and should have just gotten .5 - 1m dollars as part of the NJ program they get every year....if it is still in effect.
Are non retail MMs still playing the same games? of course....
Thats obviously not true. He just converted more warrents increasing his holdings..lol
Really? So what is Targin a generic for? LOL LOL
Since it releases Naloxone intentionally anyone with any basic understanding of pharmacology would understand just how different the drug is...from the branded Oxycodone ER...then again the FDA pulled all Oxycodone ER in favor of Purdue ADT which is easily abused via instructions all over the Internet so your point proves once again he what we already know and that is there is no reason anyone has shown as to why elite will continue to pass trials and be approved. We all know it.
You referencing the FDA is also a false illogical argument that doesn't relate to the question either but more of a red herring type analogy since it doesn't disprove Elite and doesn't really address Targin and efficacy either. .
Not once has anyone given any legitimate reason why trials won't continue to pass and if efficacy it needed why it won't pass and why it won't be approved.
It is just generic drug making...small pellets of opioid with small identical indistinguishable pellets of Naltrexone.
Each separate yet the same...
The rest is basic science and drug making.
For a company with somewhere around 25 approved drugs...and expert staff...not really very risky...
Want to see my list of potential problems?
Acts of God like an earthquake or fire....that's about it.
Interesting conversation but mostly moot.
25-40 approved drugs, pending drugs, development drugs, plus others in development with different partners--Non ART
Positive ART drug trials received and more fully expected in 8 billion dollar market
Further trials all expected to be positive
Numerous patents
Incredible leadership leading the company...attracting top talent from larger pharmas willing to come to a small company shows confidence.
No one can present any legitimate reason why Elite's ART doesn't work, won't work, won't be approved and because it is modular would represent a shift in the entire market. Elite has more products in development to prevent Abuse then anyone as far as I know
INCREDIBLY UNDERVALUED - No one is talking about the actual value and chances for real success....So when people talk about the transfer of wealth from the impatient to the patient...this is what that means.
Elite is highly likely to be successful and the returns if they are are many possible many many multiples of the current stock price....Simple
With somewhere between 25 and 40 other non ART drugs the current cap would easily be supported without ART. If you took out R&D company could be profitable now....
Yeah...not true again...but have fun
Too funny. Obviously not true in any way but funny...
That's IR...lol
Common knowledge? But you can start with their website
Interesting conversation but mostly moot.
25-40 approved drugs, pending drugs, development drugs, plus others in development with different partners--Non ART
Positive ART drug trials received and more fully expected in 8 billion dollar market
Further trials all expected to be positive
Numerous patents
Incredible leadership leading the company...attracting top talent from larger pharmas willing to come to a small company shows confidence.
No one can present any legitimate reason why Elite's ART doesn't work, won't work, won't be approved and because it is modular would represent a shift in the entire market. Elite has more products in development to prevent Abuse then anyone as far as I know
INCREDIBLY UNDERVALUED - No one is talking about the actual value and chances for real success....So when people talk about the transfer of wealth from the impatient to the patient...this is what that means.
Elite is highly likely to be successful and the returns if they are are many possible many many multiples of the current stock price....Simple
Manipulated so high
And wash trading too and million shares...wanna bet? Come on.....we barely break 1 million shares and most of that is day trading back and forth. How fast has this stock just moved 15% on little volume...
Tells you how thin it is....
The real question is why was the price manipulated so low? So far below a reasonable valuation? We all know why and that is because of where the stock is going to be run up to....
I see possible short covering on the bid and many MMs on the bid and some flippers...Its been the same though really for two plus months. The problem is that if you wanted to buy big blocks the stock would be back to the high 20s very quickly. Stock moved how far on how little volume?